These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 23041210

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin.
    Ip BK, Thomson AR, Moriarty HT.
    Pathology; 2001 Aug; 33(3):347-52. PubMed ID: 11523938
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.
    Shinoda T, Arakura H, Katakura M, Shirota T, Nakagawa S.
    Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.
    Engström M, Rundgren M, Schött U.
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):86-91. PubMed ID: 19719819
    [Abstract] [Full Text] [Related]

  • 27. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs.
    Babski DM, Brainard BM, Ralph AG, Pittman JR, Koenig A.
    J Vet Intern Med; 2012 Jul; 26(3):631-8. PubMed ID: 22435404
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.
    Drouet L, Bal dit Sollier C, Martin J.
    Am Heart J; 2009 Aug; 158(2):177-84. PubMed ID: 19619692
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).
    He S, Eelde A, Petrini P, Wallen H, Gabrielsson L, Svensson J, Blombäck M, Holmström M.
    Thromb Res; 2018 Nov; 171():7-13. PubMed ID: 30216822
    [Abstract] [Full Text] [Related]

  • 37. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S, Theaker J, Preston FE.
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P.
    Thromb Res; 2007 Mar; 120(3):347-51. PubMed ID: 17118432
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.